Dr. Rosenthal is an Associate Professor of Health Economics and Policy in the Department of Health Policy and Management at the Harvard School of Public Health.
Dr. Rosenthal’s principal research interests revolve around economic incentives that influence consumer and provider health care decisions. Her other substantive interests include the pharmaceutical industry, mental health policy, and the economics of smoking. She is currently working on a series of related projects that examine evolving trends in the health insurance market, including consumer-directed health plans and financial incentives for improving health care quality and patient safety. Dr. Rosenthal is also participating in a study that examines the prevalence, design and early effects of consumer-directed health plans.
Dr. Rosenthal has recently been involved in studying the rise of direct-to-consumer advertising (DTCA) by the pharmaceutical industry and its impact on prescription drug utilization and appropriateness of care. Dr. Rosenthal is also engaged in a study examining the relationship between provider competition and managed care entry in rural markets.